YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

SEHK:1558 株式レポート

時価総額:HK$8.0b

YiChang HEC ChangJiang Pharmaceutical バランスシートの健全性

財務の健全性 基準チェック /66

YiChang HEC ChangJiang Pharmaceuticalの総株主資本はCN¥8.7B 、総負債はCN¥2.1Bで、負債比率は23.9%となります。総資産と総負債はそれぞれCN¥12.5BとCN¥3.8Bです。 YiChang HEC ChangJiang Pharmaceuticalの EBIT はCN¥2.1Bで、利息カバレッジ比率30.4です。現金および短期投資はCN¥1.5Bです。

主要情報

23.9%

負債資本比率

CN¥2.07b

負債

インタレスト・カバレッジ・レシオ30.4x
現金CN¥1.52b
エクイティCN¥8.67b
負債合計CN¥3.83b
総資産CN¥12.49b

財務の健全性に関する最新情報

Recent updates

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Oct 07
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?

Sep 19
Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%

May 29
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%

Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?

Apr 23
Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce

Mar 01
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce

Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%

Mar 01
Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't

Jan 03
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt

Sep 25
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt

Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?

Nov 25
Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?

Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?

Mar 23
Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?

Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?

Oct 29
Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?

Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden

Apr 13
Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially

Mar 23
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially

YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.

Mar 13
YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?

Feb 20
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?

Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?

Feb 02
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Dec 26
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend

Dec 13
Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend

What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Nov 30
What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?

財務状況分析

短期負債: 1558の 短期資産 ( CN¥5.5B ) が 短期負債 ( CN¥2.5B ) を超えています。

長期負債: 1558の短期資産 ( CN¥5.5B ) が 長期負債 ( CN¥1.3B ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: 1558の 純負債対資本比率 ( 6.3% ) は 満足できる 水準であると考えられます。

負債の削減: 1558の負債対資本比率は、過去 5 年間で74.6%から23.9%に減少しました。

債務返済能力: 1558の負債は 営業キャッシュフロー によって 十分にカバー されています ( 21.9% )。

インタレストカバレッジ: 1558の負債に対する 利息支払いEBIT ( 30.4 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘